Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …

There is need for a validated short, simple instrument to quantify chronic obstructive
pulmonary disease (COPD) impact in routine practice to aid health status assessment and …

Background Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic
obstructive pulmonary disease (COPD), but their effect on survival is unknown. Methods We …

A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's
Respiratory Questionnaire Page 1 A Self-complete Measure of Health Status for Chronic …

Objectives: To determine the effect of long term inhaled corticosteroids on lung function,
exacerbations, and health status in patients with moderate to severe chronic obstructive …

Significant heterogeneity of clinical presentation and disease progression exists within
chronic obstructive pulmonary disease (COPD). Although FEV1 inadequately describes this …

Empirical software engineering research needs research guidelines to improve the research
and reporting processes. We propose a preliminary set of research guidelines aimed at …

BACKGROUND Methods of classifying chronic obstructive pulmonary disease (COPD)
depend largely upon spirometric measurements but disability is only weakly related to …